• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棘白菌素类药物卡泊芬净抗近平滑念珠菌、近平滑念珠菌、中间型念珠菌和白念珠菌的体外与体内药效比较。

Comparison of in vitro and vivo efficacy of caspofungin against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans.

机构信息

Department of Medical Microbiology, Medical and Health Science Center, University of Debrecen, Nagyerdei Krt. 98., 4032 Debrecen, Hungary.

出版信息

Mycopathologia. 2012 Oct;174(4):311-8. doi: 10.1007/s11046-012-9554-7. Epub 2012 May 8.

DOI:10.1007/s11046-012-9554-7
PMID:22565489
Abstract

Caspofungin activity was determined in vitro and in vivo against three Candida orthopsilosis, three C. metapsilosis, two C. parapsilosis sensu stricto and two C. albicans isolates. MIC values and killing activity were determined in RPMI-1640 plus 50 % human serum. Neutropenic (cyclophosphamide-treated) mice were infected intravenously. Five-day intraperitoneal treatment with caspofungin was started after 24 h postinfection. Kidney burden was analyzed using the Kruskal-Wallis test with Dunn's post-test. In killing studies, caspofungin was fungistatic and fungicidal against C. albicans at ≥0.25 and ≥2 μg/ml concentrations, respectively. Caspofungin was fungistatic at ≥8-16, ≥2-8 and at ≥2-8 μg/ml against C. parapsilosis, C. orthopsilosis and C. metapsilosis, respectively. In the murine model, C. albicans was inhibited by 1, 2 and 5 mg/kg of caspofungin (P < 0.001 compared to the controls). Against C. parapsilosis, only 5 mg/kg caspofungin was effective against both isolates (P < 0.05). Two and five mg/kg of caspofungin was effective against all C. orthopsilosis and C. metapsilosis isolates (P < 0.05 to <0.001). Serum-based killing tests proved to be useful in predicting in vivo efficacy of caspofungin against four Candida species. Caspofungin at clinically attainable concentrations proved to be effective against all four species.

摘要

棘白菌素对三种近平滑念珠菌、三种中间型念珠菌、两种近平滑假丝酵母和两种白念珠菌分离株的体外和体内活性进行了测定。在 RPMI-1640 中添加 50%人血清,测定 MIC 值和杀伤活性。用环磷酰胺处理的中性粒细胞减少症小鼠经静脉感染。感染后 24 小时开始进行为期 5 天的腹腔内注射治疗。用 Kruskal-Wallis 检验和 Dunn's 事后检验分析肾脏负担。在杀伤研究中,棘白菌素对白色念珠菌的抑菌和杀菌浓度分别为≥0.25 和≥2μg/ml。棘白菌素对近平滑假丝酵母、近平滑念珠菌和中间型念珠菌的抑菌浓度分别为≥8-16、≥2-8 和≥2-8μg/ml。在小鼠模型中,1、2 和 5mg/kg 的棘白菌素抑制了白色念珠菌(与对照组相比,P<0.001)。对近平滑假丝酵母,只有 5mg/kg 的棘白菌素对两种分离株有效(P<0.05)。2 和 5mg/kg 的棘白菌素对所有的近平滑念珠菌和中间型念珠菌分离株均有效(P<0.05 至<0.001)。基于血清的杀伤试验被证明可用于预测棘白菌素对四种念珠菌的体内疗效。在临床上可达到的浓度下,棘白菌素对所有四种念珠菌均有效。

相似文献

1
Comparison of in vitro and vivo efficacy of caspofungin against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans.棘白菌素类药物卡泊芬净抗近平滑念珠菌、近平滑念珠菌、中间型念珠菌和白念珠菌的体外与体内药效比较。
Mycopathologia. 2012 Oct;174(4):311-8. doi: 10.1007/s11046-012-9554-7. Epub 2012 May 8.
2
In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.棘白菌素类药物对近平滑念珠菌、近平滑假丝酵母和中间假丝酵母的体外和体内作用。
J Antimicrob Chemother. 2012 Sep;67(9):2195-202. doi: 10.1093/jac/dks180. Epub 2012 May 25.
3
Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.台湾地区近平滑念珠菌、中间型念珠菌和副近平滑念珠菌的分子流行病学和抗真菌药敏性。
Diagn Microbiol Infect Dis. 2010 Nov;68(3):284-92. doi: 10.1016/j.diagmicrobio.2010.07.004. Epub 2010 Sep 20.
4
Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.在暂时中性粒细胞减少的小鼠模型中,用氟康唑、两性霉素 B 和卡泊芬净治疗近平滑念珠菌复合体各菌种所致实验性播散性念珠菌病,比较其肾脏真菌负荷。
Chemotherapy. 2012;58(2):159-64. doi: 10.1159/000337088. Epub 2012 May 24.
5
Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
New Microbiol. 2014 Jul;37(3):355-62. Epub 2014 Jul 1.
6
[Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].[南特医院5年期间念珠菌血症中近平滑念珠菌、正平滑念珠菌和副平滑念珠菌的患病率以及通过E-test®对三种棘白菌素的体外敏感性]
Pathol Biol (Paris). 2011 Feb;59(1):52-6. doi: 10.1016/j.patbio.2010.07.019. Epub 2010 Sep 15.
7
Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades.卡泊芬净对白色念珠菌和近平滑念珠菌分支的抗真菌后效应。
Diagn Microbiol Infect Dis. 2016 Oct;86(2):172-7. doi: 10.1016/j.diagmicrobio.2016.07.011. Epub 2016 Jul 12.
8
Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology.采用时间杀菌法研究尼可霉素Z和50%人血清对高浓度卡泊芬净抗念珠菌属杀菌活性的影响。
J Chemother. 2012 Feb;24(1):18-25. doi: 10.1179/1120009X12Z.0000000005.
9
In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.体外杀菌活性的棘白菌素类药物对念珠菌属 metapsilosis 、 C. orthopsilosis 和 C. parapsilosis 通过时间杀死研究评估。
Antimicrob Agents Chemother. 2010 May;54(5):2194-7. doi: 10.1128/AAC.01538-09. Epub 2010 Feb 9.
10
In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.通过时间杀菌法测定5种抗真菌剂对近平滑念珠菌、正平滑念珠菌和间平滑念珠菌的体外疗效。
Diagn Microbiol Infect Dis. 2009 Jul;64(3):283-8. doi: 10.1016/j.diagmicrobio.2009.03.011. Epub 2009 Apr 25.

引用本文的文献

1
Threats from the complex: the surge of multidrug resistance and a hotbed for new emerging pathogens.复杂因素带来的威胁:多重耐药性的激增以及新出现病原体的温床。
Microbiol Mol Biol Rev. 2024 Dec 18;88(4):e0002923. doi: 10.1128/mmbr.00029-23. Epub 2024 Nov 7.
2
The Emerging Pathogen : Biological Aspects, Virulence Factors, Diagnosis, and Treatment.新兴病原体:生物学特性、毒力因子、诊断与治疗
Infect Drug Resist. 2024 Jan 20;17:171-185. doi: 10.2147/IDR.S448213. eCollection 2024.
3
Postantifungal Effect of Antifungal Drugs against : What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

本文引用的文献

1
Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology.采用时间杀菌法研究尼可霉素Z和50%人血清对高浓度卡泊芬净抗念珠菌属杀菌活性的影响。
J Chemother. 2012 Feb;24(1):18-25. doi: 10.1179/1120009X12Z.0000000005.
2
Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model.在中性粒细胞减少小鼠模型中,单次6mg/kg与两次3mg/kg卡泊芬净剂量治疗白色念珠菌引起的播散性念珠菌病的疗效比较。
J Chemother. 2011 Apr;23(2):107-9. doi: 10.1179/joc.2011.23.2.107.
3
抗真菌药物的抗真菌后效应:我们了解什么以及如何在临床环境中应用这些知识?
J Fungi (Basel). 2022 Jul 12;8(7):727. doi: 10.3390/jof8070727.
4
Crosstalk between the calcineurin and cell wall integrity pathways prevents chitin overexpression in Candida albicans.钙调神经磷酸酶和细胞壁完整性途径之间的串扰可防止白念珠菌中几丁质的过度表达。
J Cell Sci. 2021 Dec 15;134(24). doi: 10.1242/jcs.258889. Epub 2021 Dec 16.
5
Antifungal Activity of an Original Amino-Isocyanonaphthalene (ICAN) Compound Family: Promising Broad Spectrum Antifungals.一种新型的氨基异氰基萘(ICAN)化合物家族的抗真菌活性:有前途的广谱抗真菌药物。
Molecules. 2020 Feb 18;25(4):903. doi: 10.3390/molecules25040903.
6
Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.在 RPMI-1640 培养基、10% 和 30% 血清中比较米卡芬净对来源于腹腔和胸腔的六种念珠菌的杀菌活性。
Mycopathologia. 2018 Dec;183(6):905-912. doi: 10.1007/s11046-018-0302-5. Epub 2018 Oct 31.
7
Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.米卡芬净对人血清存在时白念珠菌、杜波依斯念珠菌和非洲念珠菌的杀伤活性。
Mycopathologia. 2017 Dec;182(11-12):979-987. doi: 10.1007/s11046-017-0178-9. Epub 2017 Jul 11.
8
Dose escalation studies with caspofungin against Candida glabrata.卡泊芬净针对光滑念珠菌的剂量递增研究。
J Med Microbiol. 2015 Sep;64(9):998-1007. doi: 10.1099/jmm.0.000116. Epub 2015 Jun 30.
9
Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.在有血清和无血清情况下,短暂和持续暴露于卡泊芬净后,卡泊芬净对白色念珠菌的杀菌率。
Mycopathologia. 2014 Oct;178(3-4):197-206. doi: 10.1007/s11046-014-9799-4. Epub 2014 Aug 15.
10
Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility.阿尼芬净与卡泊芬净在对阿尼芬净敏感的近平滑念珠菌分离株所致念珠菌病的小鼠模型中的比较,这些分离株对卡泊芬净的敏感性存在不同程度的差异。
Antimicrob Agents Chemother. 2014;58(1):229-36. doi: 10.1128/AAC.01025-13. Epub 2013 Oct 21.
Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasis.
卡泊芬净在中枢神经系统念珠菌病幼年小鼠模型中的疗效。
Antimicrob Agents Chemother. 2011 Jul;55(7):3491-7. doi: 10.1128/AAC.01328-10. Epub 2011 Apr 25.
4
Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin.通过使用添加牛血清白蛋白的 CLSI M27-A3 文档方法,提高对 Candida sp. fks 热点突变体的检测。
Antimicrob Agents Chemother. 2011 May;55(5):2245-55. doi: 10.1128/AAC.01350-10. Epub 2011 Mar 7.
5
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.重新审视棘白菌素类药物和念珠菌的临床折点:整合分子、临床和微生物学数据,以制定出基于物种的解释标准。
Drug Resist Updat. 2011 Jun;14(3):164-76. doi: 10.1016/j.drup.2011.01.004. Epub 2011 Feb 24.
6
Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participants.健康成年参与者中更高剂量卡泊芬净的安全性和药代动力学。
J Clin Pharmacol. 2011 Feb;51(2):202-11. doi: 10.1177/0091270010374853. Epub 2010 Aug 2.
7
In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.体外杀菌活性的棘白菌素类药物对念珠菌属 metapsilosis 、 C. orthopsilosis 和 C. parapsilosis 通过时间杀死研究评估。
Antimicrob Agents Chemother. 2010 May;54(5):2194-7. doi: 10.1128/AAC.01538-09. Epub 2010 Feb 9.
8
Antifungal activity of micafungin in serum.米卡芬净在血清中的抗真菌活性。
Antimicrob Agents Chemother. 2009 Oct;53(10):4559-62. doi: 10.1128/AAC.01404-08. Epub 2009 Aug 17.
9
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.一项针对成年侵袭性念珠菌病患者的高剂量卡泊芬净治疗方案与标准卡泊芬净治疗方案的多中心双盲试验。
Clin Infect Dis. 2009 Jun 15;48(12):1676-84. doi: 10.1086/598933.
10
In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.通过时间杀菌法测定5种抗真菌剂对近平滑念珠菌、正平滑念珠菌和间平滑念珠菌的体外疗效。
Diagn Microbiol Infect Dis. 2009 Jul;64(3):283-8. doi: 10.1016/j.diagmicrobio.2009.03.011. Epub 2009 Apr 25.